Development of an Imaging Prediction Model for Pelvic Lymph Node Metastasis of Cervical Cancer Using Artificial Intelligence Techniques.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-80
SponsorObstetrics & Gynecology Hospital of Fudan University

About this trial

This study is a retrospective exploratory trial conducted at a single center, aiming to develop and validate a preoperative lymphatic metastasis model for cervical cancer using artificial intelligence deep learning. The model is trained using preoperative imaging and postoperative pathological findings of cervical cancer patients, with the goal of enhancing the accuracy of lymphatic metastasis prediction through preoperative imaging and offering insights for treatment decisions.

Eligibility criteria

Qualifiers

patients with preoperative diagnosis of invasive cervical cancer stage I-III, with any type of pathology, and patients who underwent radical/modified radical cervical cancer surgery + pelvic lymph node dissection in our hospital.

Age ≥18 years old and ≤80 years old

patients with complete preoperative pelvic MRI images and postoperative pathology and clinical data in our hospital

Disqualifiers

Patients during pregnancy or breastfeeding, patients within 42 days of abortion

Patients who have received neoadjuvant chemotherapy or radiotherapy before surgery for this previous cervical cancer

Patients with other malignant tumors within 5 years

Combination of other underlying diseases that may lead to enlarged pelvic lymph nodes

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed